Developer of orphan medicinal products. The company's orphan medicinal products include Cystadane, Cystagon, Normosang and Wilzin for metabolic disorders, enabling patients to access a wide range of products for their treatment under one roof.
What you see here scratches the surface
We’ll help you find what you need
This information is available in the PitchBook Platform. To explore Orphan Europe‘s full profile, request access.
© 2020 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.